U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07409740) titled 'Optical Coherence Tomography Angiography Evaluation Of Patients Taking Hydroxychloroquine' on Jan. 28.
Brief Summary: This study aims to evaluate retinal and choroidal microvascular changes using optical coherence tomography angiography (OCTA) in patients receiving hydroxychloroquine therapy. Hydroxychloroquine is commonly used in the treatment of autoimmune diseases and may cause retinal toxicity with long-term use. OCTA is a non-invasive imaging modality that allows detailed assessment of retinal vascular changes.
Study Start Date: Feb. 01
Study Type: OBSERVATIONAL
Condition:
Hydroxychloroquine Retinopathy
Recruitment Status:...